Man

Alvaro Fernando Lladser Caldera

Professor, Principal Investigator

FUNDACIÓN CIENCIA PARA LA VIDA

Santiago, Chile

Líneas de Investigación


Study of antitumor immunity, in particular CD8+ T cells, and harnessing this knowledge to design strategies promoting tumor elimination.

Educación

  •  Biochemist, UNIVERSIDAD DE CHILE. Chile, 2001
  •  Biochemistry, UNIVERSIDAD DE CHILE. Chile, 1999
  •  Inmunología, UNIVERSIDAD DE CHILE. Chile, 2007

Experiencia Académica

  •   Principal Investigator, Laboratory of Immunoncology Full Time

    FUNDACION CIENCIA PARA LA VIDA

    Santiago, Chile

    2010 - A la fecha

  •   Postdoctoral Investigator Full Time

    KAROLINSKA INSTITUTE

    Cancer Center Karolinska

    Stockholm, Suecia

    2007 - 2010

Experiencia Profesional

  •   Undergraduate student Full Time

    Gene Pharmacotherapy Lab, Faculty of Chemical and Pharmaceutical, Universidad de Chile

    Chile

    2000 - 2001

  •   Research Assistant Full Time

    Gene Pharmacotherapy Lab, Faculty of Chemical and Pharmaceutical Sciences , Universidad de Chile

    Chile

    2002 - 2002

  •   Graduate student Full Time

    Cell comunication Lab, Faculty of Medicine, Universidad de Chile

    Chile

    2004 - 2007

  •   Postdoctoral investigator Full Time

    Cancer Center Karolinska (CCK), Karolinska Institutet

    Suecia

    2007 - 2010

  •   Principal Investigator Full Time

    Fundación Ciencia para la Vida

    Chile

    2010 - A la fecha

Formación de Capital Humano


RESEARCH GRANTS
2025-2021 Principal Investigator FONDECYT Regular Grant 1212070.
2021-2010 Principal Investigator Basal Funding Program AFB 170004 to Fundación Ciencia & Vida
2022-2018 Co-Investigator FONDECYT Regular Grant 1180385. PI: Dr. Daniela Sauma.
2021-2017 Principal Investigator FONDECYT Regular Grant 1171703.
2018-2017 Principal Investigator FONDEF IDeA ID16I10369.
2017-2013 Co-Investigator FONDECYT Regular Grant 1130271. PI: Dr. Rodrigo Pacheco.
2016-2012 Principal Investigator CORFO-Innova L2 I+D Aplicada 12IDL2-13348.
2016-2012 Sponsor Investigator FONDECYT Postdoctoral Grant 3130764.
2016-2012 Co-Investigator CORFO-Innova L2 I+D Aplicada 12IDL2-16030. PI: Dr. Rodrigo Pacheco
2014-2011 Principal Investigator FONDECYT Starting Grant 11110525.
2014-2011 Principal Investigator CONICYT Insertion in the Academy Grant 791100038.

PEER REVIEW PANELS
2020-2019 Director Study Group FONDECYT “Biology 2”
2018-2017 Member Study Group FONDECYT “Biology 2”
2014-2013 Reviewer committee FONDEF grants
Since 2020 Reviewer for Nature Communications
Since 2020 Reviewer for Journal for ImmunoTherapy of Cancer
2015-2021 Associate Editor for Human Vaccines & Immunotherapeutics

MEMBERSHIPS
Since 2019 Vice-President ASOCHIN – Asociación Chilena de Inmunología.
Since 2018 Member EATI – European Academy of Tumor Immunology
Since 2017 Member ASOCHIN – Asociación Chilena de Inmunología.
Since 2017 Member SBCCH – Sociedad de Biología Celular de Chile

POSTDOCTORAL SUPERVISION
Since 2021 Dr. Farides Saavedra
2016-2012 Dr. Paola Murgas. Postdoctoral FONDECYT Grant 3130764.
2012-2011 Dr. Andrés Herrada.

THESIS SUPERVISION
Finished PhD Theses
2019 Evelyn Menares. PhD in Biotechnology, Universidad Andrés Bello.
2018 Felipe Gálvez. PhD in Biotechnology, Universidad Andrés Bello.
2016 Nicole Rojas. PhD in Biotechnology, Universidad Andrés Bello.
2015 César Oyarce. PhD in Biomedical Sciences, Universidad de Chile.
2015 Maarten Ligtenberg. PhD in Medical Sciences, Karolinska Institute. Sweden.

Ongoing PhD Theses
Since 2018 Sofia Hidalgo. PhD in Biotechnology, Universidad Andrés Bello.
Since 2019 Diego Figueroa. PhD in Biotechnology, Universidad Andrés Bello.

Finished Magister Theses

2020 Nicolás Méndez. Magister in Biotechnology, Universidad Andrés Bello.
2019 Pablo Cáceres. Magister in Biochemistry, Universidad de Chile.
2018 Ornella Chovar. Magister in Biological Sciences, Universidad de Chile.
2016 Ernesto López. Magister in Biological Sciences, Universidad de Chile.
2017 Luis Mourgues. Magister in Biotechnology, Universidad Andrés Bello.
2017 Sebastián Cruz. Magister in Biochemistry, Universidad de Chile.
2016 Eduardo Durán. Magister in Biochemistry, Universidad de Concepción.
2014 Nicolás Bustamante. Magister in Biological Sciences, Universidad de Chile.

Ongoing Magister Thesis

Since 2020 Francisca Hofmann. Magister in Biotechnology, Universidad Andrés Bello.

Finished Undergraduate Theses
2019 Juan Saavedra. Engineering in Molecular Biotechnology, Universidad de Chile.
2019 Javiera Gómez. Biochemistry, Universidad de Santiago de Chile.
2016 Ernesto López. Engineering in Molecular Biotechnology, Universidad de Chile.
2016 Camila Flores. Engineering in Molecular Biotechnology, Universidad de Chile.
2016 Nicole Araya. Biotechnology, Universidad Mayor.
2016 Felipe Gálvez. Pharmaceutical Chemistry, Universidad de Chile.
2014 Sebastián Cruz. Biology, Pontificia Universidad Católica de Valparaíso.
2012 Jonathan Roco. Biochemistry, Pontificia Universidad Católica de Chile.
2012 Paula González. Biotechnology, Universidad de la Frontera.

Ongoing Undergraduate Theses
2020 Brian Sirguiado. Engineering in Biotechnology, Universidad Andrés Bello.
2020 Pablo Contreras. Engineering in Biotechnology, Universidad Andrés Bello.


Difusión y Transferencia


Participation in Opinion Leader Workshop, 2012 - 2015. Moderator Biotechnology Session at Encounters Chile Global, Santiago. 2014 “Biomedicina, una carrera contra el tiempo: desde la idea al paciente” ("Biomedicine, a race against time: from idea to patient")

OUTREACH & MEDIA

2020 Interview in television channel Mega Plus, program Mundo Plus, (February 2020)
Url: https://www.lun.com/Pages/NewsDetail.aspx?dt=2019-10-01&NewsID=437320&BodyID=0&PaginaId=8
2020 Interview in online radio program TXS Health in TxS Radio (February 2020)
Url: https://youtu.be/sejFpoxkKLU
2019 Article in national newspaper LUN (1 October 2019)
Url: https://www.lun.com/Pages/NewsDetail.aspx?dt=2019-10-01&NewsID=437320&BodyID=0&PaginaId=8
2018 Program in national television channel 24 Horas (28 November 2018)
Url: https://www.24horas.cl/programas/exploradores/exploradores---miercoles-28-de-noviembre-2897898
2018 Report in national television newscast at Chilevision about the 2018 Nobel Prize (1 October 2018)
Url: https://www.futuro360.com/data/padres-de-la-inmunoterapia-contra-el-cancer-son-ganadores-del-premio-nobel-de-medicina_20181001/
2018 Interview in Radio Pauta, program “La Invención del Futuro” (1 October 2018)
Url: http://www.pauta.cl/programas/la-invencion-del-futuro/alvaro-lladser-sobre-el-descubrimiento-clave-del-cancer
2018 Article in online newspaper El Mostrador (8 October 2018)
Url: http://www.elmostrador.cl/cultura/2018/10/08/la-investigacion-chilena-contra-el-cancer-para-fortalecer-el-sistema-inmunologico/
2018 Article in national newspaper LUN (31 March 2018)
Url: http://www.lun.com/Pages/NewsDetail.aspx?dt=2018-03-31&NewsID=397338&BodyID=0&PaginaId=2


Premios y Distinciones

  •   Alvaro Lladser

    Progress In Vaccination Against Cancer PIVAC-10

    Reino Unido, 2010

    Best poster, “DAI (ZBP1/DLM-1) as a genetic adjuvant for DNA vaccines that promotes antitumor CTL immunity”

  •   Alvaro Lladser

    DNA Vaccines 2011: Building on Clinical Progress and Exploring New Targets

    Estados Unidos, 2011

    Outstanding summary, “Harnessing DNA-sensing pathways of innate immunity for DNA vaccines against cancer”

  •   Alvaro Lladser

    Cell Biology society of Chile

    Chile, 2013

    Best Undergratuate poster (Felipe Gálvez Cancino). "NFkB activation during intradermal DNA vaccination controls migration of skin-derived dendritic cells and induction of tumor-protective CTL responses".

  •   Alvaro Lladser

    Annual Meeting of the Association for Cancer Immunotherapy (CIMT): "Next waves in cancer immunotherapy"

    Alemania, 2014

    Awarded Best Poster category "Improving Immunity" (Nicole Rojas Colonelli). "DNA vaccination in combination with an RNAi-based genetic adjuvant silencing STAT3 promotes migration of mature dermal dendritic cells and antitumor T cell responses against B16 melanoma".

  •   Alvaro Lladser

    Cell Biology Society of Chile

    Chile, 2015

    Best Postraduate poster (Ernesto López)

  •   Alvaro Lladser

    Chilean Immunology Association

    Chile, 2017

    Best doctoral poster (Felipe Gálvez)


 

Article (46)

Nuanced role for dendritic cell intrinsic IRE1 RNase in the regulation of antitumor adaptive immunity
Preclinical evaluation of chimeric antigen receptor T cells targeting the carcinoembryonic antigen as a potential immunotherapy for gallbladder cancer
S-Nitrosylation in endothelial cells contributes to tumor cell adhesion and extravasation during breast cancer metastasis
Deciphering immunoregulatory vulnerabilities in human cancers
Dopaminergic Signalling Enhances IL-2 Production and Strengthens Anti-Tumour Response Exerted by Cytotoxic T Lymphocytes in a Melanoma Mouse Model
CD73 Ectonucleotidase Restrains CD8+ T Cell Metabolic Fitness and Anti-tumoral Activity
Ecto-5'-Nucleotidase (CD73) Regulates the Survival of CD8+ T Cells
The Heteromeric Complex Formed by Dopamine Receptor D5 and CCR9 Leads the Gut Homing of CD4+ T Cells Upon Inflammation
Caveolin-1-Mediated Tumor Suppression Is Linked to Reduced HIF1 alpha S-Nitrosylation and Transcriptional Activity in Hypoxia
Loss of Caveolin-1 Is Associated with a Decrease in Beta Cell Death in Mice on a High Fat Diet
Transcriptional and Functional Analysis of CD1c(+) Human Dendritic Cells Identifies a CD163(+) Subset Priming CD8(+)CD103(+) T Cells
Analysis of Tissue-Resident Immune Cells from Mouse Skin and Lungs by Flow Cytometry.
Coagulation Factor Xa Promotes Solid Tumor Growth, Experimental Metastasis and Endothelial Cell Activation
Immunotherapeutic Potential of Mollusk Hemocyanins in Combination with Human Vaccine Adjuvants in Murine Models of Oral Cancer
Immunotherapeutic Potential of Mollusk Hemocyanins in Combination with Human Vaccine Adjuvants in Murine Models of Oral Cancer
Small Extracellular Vesicles Released from Ovarian Cancer Spheroids in Response to Cisplatin Promote the Pro-Tumorigenic Activity of Mesenchymal Stem Cells
STAT3 Activation in Combination with NF-KappaB Inhibition Induces Tolerogenic Dendritic Cells with High Therapeutic Potential to Attenuate Collagen-Induced Arthritis
Tissue-resident memory CD8(+) T cells amplify anti-tumor immunity by triggering antigen spreading through dendritic cells
Tissue-resident memory CD8+ T cells amplify anti-tumor immunity by triggering antigen spreading through dendritic cells
A filamentous bacteriophage targeted to carcinoembryonic antigen induces tumor regression in mouse models of colorectal cancer
Cripto-1 Plasmid DNA Vaccination Targets Metastasis and Cancer Stem Cells in Murine Mammary Carcinoma
Dopaminergic stimulation of Myeloid antigen-Presenting cells attenuates signal Transducer and activator of Transcription 3-activation Favouring the Development of experimental autoimmune encephalomyelitis
In Vitro-generated Tc17 cells Present a Memory Phenotype and serve as a reservoir of Tc1 cells In Vivo
In vivo knockdown of antisense non-coding mitochondrial RNAs by a lentiviral-encoded shRNA inhibits melanoma tumor growth and lung colonization
IRE1 alpha Activation in Bone Marrow-Derived Dendritic Cells Modulates Innate Recognition of Melanoma Cells and Favors CD8(+) T Cell Priming
Vaccination-induced skin-resident memory CD8(+) T cells mediate strong protection against cutaneous melanoma
A short hairpin RNA-based adjuvant targeting NF-kappa B repressor I kappa B alpha promotes migration of dermal dendritic cells to draining lymph nodes and antitumor CTL responses induced by DNA vaccination
Caveolin-1 Expression Increases upon Maturation in Dendritic Cells and Promotes Their Migration to Lymph Nodes Thereby Favoring the Induction of CD8(+) T Cell Responses
Caveolin-1 Expression Increases upon Maturation in Dendritic Cells and Promotes Their Migration to Lymph Nodes Thereby Favoring the Induction of CD8+ T Cell Responses
Inhibition of dopamine receptor D3 signaling in dendritic cells increases antigen cross-presentation to CD8(+) T-cells favoring anti-tumor immunity
Coexpressed Catalase Protects Chimeric Antigen Receptor-Redirected T Cells as well as Bystander Cells from Oxidative Stress-Induced Loss of Antitumor Activity
Cripto-1 vaccination elicits protective immunity against metastatic melanoma
Dopamine Receptor D3 Signaling on CD4(+) T Cells Favors Th1-and Th17-Mediated Immunity
Purinergic Signaling as a Regulator of Th17 Cell Plasticity
E-cadherin determines Caveolin-1 tumor suppression or metastasis enhancing function in melanoma cells
NF-kappa B activation during intradermal DNA vaccination is essential for eliciting tumor protective antigen-specific CTL responses
Tumour cell lysate-loaded dendritic cell vaccine induces biochemical and memory immune response in castration-resistant prostate cancer patients
Harnessing DNA-induced immune responses for improving cancer vaccines
Stimulation of Dopamine Receptor D5 Expressed on Dendritic Cells Potentiates Th17-Mediated Immunity
DAI (DLM-1/ZBP1) as a Genetic Adjuvant for DNA Vaccines That Promotes Effective Antitumor CTL Immunity
Is survivin the potential Achilles’ heel of cancer?.
Intradermal DNA electroporation induces survivin-specific CTLs, suppresses angiogenesis and confers protection against mouse melanoma
Regulatory T cells in cancer
E-cadherin is required for caveolin-1-mediated down-regulation of the inhibitor of apoptosis protein survivin via reduced beta-Catenin-Tcf/Lef-dependent transcription
Naked DNA immunization as an approach to target the generic tumor antigen survivin induces humoral and cellular immune responses in mice
Use of an acetaldehyde clamp" in the determination of low-K-M aldehyde dehydrogenase activity in H4-II-E-C3 rat hepatoma cells"

Abstract (3)

Analysis of immune responses and tumor protection in C57/Bl6 mice immunized with altered CD8 survivin peptide ligands.
Caveolin-1 reduced HIF1 alpha transcriptional activity in hypoxic cancer cells via nitric oxide synthase inhibition
E-cadherin is a molecular switch for Caveolin-1 function in melanoma cells that synergizes in tumor suppression and blocks Caveolin-1-enhanced metastasis

ConferencePoster (23)

Caveolin-1 promotes CCL21-dependent chemotactic migration of dendritic cells to lymph nodes
Cripto-1 is a potential novel target for renal cancer stem cells
Reciprocal regulation between skin resident memory CD8+ T cells and CD103+ dermal dendritic cells
Skin-resident memory CD8+ T cells mediate protective immunity against cutaneous melanoma in mice
Vaccination-induced skin-resident memory CD8+ T cells mediate rejection of cutaneous melanoma in mice
Caveolin-1 is required for LPS-induced dendritic cell maturation
Intradermal vaccination generates skin-resident memory CD8 T cells with enhanced effector properties
OX40 signaling confers resistance to lactic acid in T cells transduced with chimeric antigen receptors
Caveolin-1 is required for dendritic cell maturation and migration to peripheral lymph nodes
Cripto-1 encoding DNA vaccine elicits tumor protective immune response in vivo
DNA vaccination in combination with an RNAi-based genetic adjuvant silencing STAT3 promotes migration of mature dermal dendritic cells and antitumor T cell responses against B16 melanoma
RNAi-based silencing of STAT3 during intradermal DNA vaccination promotes antitumor T cell immunity
DNA vaccination with an shRNA silencing STAT3 improves antitumor T cell responses in a mouse melanoma model
NF-κB activation during DNA vaccination is essential for eliciting tumor protective antigen-specific CTL responses after intradermal DNA electroporation
NFκB activation during intradermal DNA vaccination controls migration of skin-derived dendritic cells and induction of tumor-protective CTL responses
An shRNA-based adjuvant against IκBα promotes antitumor T cell responses mediated by DNA vaccines
Caveolin-1 and β-catenin levels are increased in LPS-stimulated dendritic cells
Development of an RNAi-based genetic adjuvant silencing STAT3 for DNA vaccines against tumors
Optimizing the retroviral transduction of T cells with chimeric antigen receptors (CARs) against the carcinoembryonic antigen (CEA) for a potential antitumor immunotherapy
A lentivirus encoding RNAi targeting a non-coding mitochondrial RNA inhibits melanoma tumor growth and metastasis in a mouse model
Activating the β–catenin pathway modulates the phenotype of dendritic cells
Characterizing the DNA-sensing signaling pathways of the innate immunity that mediate the induction of antitumor T cell immunity elicited by DNA vaccines: the role of NF-κB
Developing an RNAi-based genetic adjuvant silencing STAT3 that counteracts tumor-associated tolerance

ConferenceProceedingWhole (2)

Caveolin-1 inhibits transcription by hypoxia inducible factor-1α in tumor cells
Harnessing DNA-sensing pathways of innate immunity for DNA vaccines against cancer

Proyecto (15)

Ingeniería genética de linfocitos T con receptores quiméricos para el desarrollo de inmunoterapias contra el cáncer
UNVEILING THE ROLE OF RESIDENT MEMORY CD8 T CELLS IN ANTITUMOR IMMUNITY
UNVEILING THE ROLE OF RESIDENT MEMORY CD8 T CELLS IN ANTITUMOR IMMUNITY
INGENIERÍA GENÉTICA DE LINFOCITOS T CON RECEPTORES QUIMÉRICOS PARA EL DESARROLLO DE INMUNOTERAPIAS CONTRA EL CÁNCER
ROLE OF DOPAMINE RECEPTORS EXPRESSED ON CD4 T-CELLS AND ON DENDRITIC CELLS IN THE DEVELOPMENT OF AUTOIMMUNE RESPONSE AND IN CELLULAR MECHANISMS INVOLVED IN THE PHYSIOPATHOLOGY OF MULTIPLE SCLEROSIS
Role of dopamine receptors expressed on CD4+ T-cells and on dendritic cells in the development of autoimmune response and in cellular mechanisms involved in the physiopathology of Multiple Sclerosis
DESARROLLO DE UNA INMUNOTERAPIA CONTRA CANCERES DEL APARATO DIGESTIVO BASADA EN BACTERIOFAGOS ESPECIFICOS PARA EL ANTIGENO CEA
DESARROLLO DE UNA INMUNOTERAPIA CONTRA CÁNCERES DEL APARATO DIGESTIVO BASADA EN BACTERIÓFAGOS ESPECÍFICOS PARA EL ANTÍGENO CEA
Desarrollo de una inmunoterapia para cánceres del aparato digestivo basada en bacteriófagos específicos para el antígeno CEA
Utilización de vectores lentivirales para el desarrollo de una terapia génica para la artritis
DEVELOPMENT OF RNAI-BASED GENETIC ADJUVANTS MODULATING MASTER REGULATORS OF IMMUNITY AND TOLERANCE TO ENHANCE THE POTENCY OF GENE VACCINES AGAINST CANCER
Development of RNAi-based genetic adjuvants modulating master regulators of immunity and tolerance to enhance the potency of gene vaccines against cancer
Fortalecimiento de la investigación, el entrenamiento de capital humano avanzado y el emprendimiento en la Fundación Ciencia para la Vida
FUNDACIÓN CIENCIA PARA LA VIDA
Fundación Ciencia y Vida

Review (4)

The function and dysfunction of memory CD8(+) T cells in tumor immunity
Harnessing DNA-induced immune responses for improving cancer vaccines
Is Survivin the Potential Achilles' Heel of Cancer?
Regulatory T Cells in Cancer
85
Alvaro Lladser

Professor, Principal Investigator

FUNDACIÓN CIENCIA PARA LA VIDA

Santiago, Chile

7
Rodrigo Pacheco

Associate Investigator; Head of the Laboratory of Neuroimmunology

Fundación Ciencia para la Vida

Santiago, Chile

6
Andrew Quest

Full Professor

Biologia Celular y Molecular

FACULTAD DE MEDICINA, UNIVERSIDAD DE CHILE

Santiago, Chile

4
Carolina Prado

Investigador Joven

Fundacion Ciencia y Vida

Santiago, Chile

4
Lisette Leyton

Full Professor

Cell and Molecular Biology

FACULTAD DE MEDICINA UNIVERSIDAD DE CHILE

Santiago, Chile

4
HUGO GONZALEZ

Associate Professor

Fundación Ciencia y Vida

Santiago, Chile

4
Cesar Oyarce Diaz

Posdtoc

MMB

UMCG

Groningen, Holanda

4
MANUEL VARAS

Research Professor

UNIVERSIDAD SAN SEBASTIÁN

Santiago, Chile

4
Daniela Sauma

Academic and researcher

Biologia

Universidad de Chile

Santiago, Chile

3
Valentina Ugalde

Lab Manager

Laboratorio de Neuroinmunología

Fundación Ciencia & Vida

Santiago, Chile

3
Lorena Lobos

Principal Investigator-Associate Proffesor

Facultad of Medicine - Clinic Alemana

Universidad Del Desarrollo

santiago, Chile

3
Paola Murgas

Profesor Investigador Asistente

Facultad de Ciencias

Universidad Austral de Chile

Valdivia , Chile

3
Francisco Contreras

Investigador en área de Investigación y Desarrollo de productos biológicos

Centrovet Ltda.

Santiago, Chile

3
Flavio Salazar

Profesor titular

Instituto de ciencias biomédicas

Universidad de Chile

SANTIAGO, Chile

2
LORENA AGUILAR

Assistant Professor

Animal Pathology

Faculty of Veterinary Medicine and Livestock Sciences, University of Chile

Santiago, Chile

2
Hery Urra

Staff scientist

INSTITUTO DE NEUROCIENCIA BIOMEDICA (BNI)

Santiago, Chile

2
Vicente Torres

Associate Professor

Institute for Research in Dental Sciences

FACULTAD DE ODONTOLOGÍA - UNIVERSIDAD DE CHILE

Santiago, Chile

2
María Becker

Scientific Director, President

Research and Development

FUNDACIÓN CIENCIA Y TECNOLOGÍA PARA EL DESARROLLLO

Santiago, Chile

2
Mercedes López

Profesora Asociada

Instituto de Ciencias Biomédicas

Universidad de chile

Santiago, Chile

2
Fabiola Osorio

Associate Professor

Programa Disciplinario de Inmunologia

Universidad de Chile

Santiago, Chile

2
Sofía Hidalgo

Investigadora Postdoctoral

Departamento de Biología

Universidad de Chile

Santiago, Chile

2
Evelyn Menares

investigador postdoctoral

programa disciplinario de inmunología

Universidad de Chile

santiago, Chile

2
Sarah Nuñez

Académico Investigador

Facultad de Ciencias de la Salud

Universidad San Sebastián

Santiago, Chile

2
Maria Bono

Profesor titular

Biologia

UNIVERSIDAD DE CHILE

Santiago, Chile

2
Mario Rosemblatt

Executive Director

-

Fundacion Ciencia & Vida

Santiago, Chile

1
Gareth Owen

Profesor Titular

Fisiologia

PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE

Santiago, Chile

1
Lilian Jara

Titular Professor

Human Molecular Genetic

UNIVERSIDAD DE CHILE / FACULTAD DE MEDICINA

Santiago, Chile

1
Julio Tapia

Profesor Asociado

Oncologia Basico Clinica

Universidad de Chile

Santiago, Chile

1
Augusto Manubens

Director

Tecnical Support

BIOSONDA S.A.

Santiago, Chile

1
Ximena Diaz

Asistente de investigación

Fundación ciencia y vida

Santiago, Chile

1
Mauricio Pinto

Investigador

STORM SPA

Santiago, Chile

1
Christopher Fitzpatrick

Postoctoral Researcher

Non coding RNAs

Fundación Ciencia y Vida

Santiago, Chile

1
Vincenzo Borgna

Investigador

Inmuno-Oncología

FUNDACION CIENCIA VIDA

Santiago, Chile

1
Victoria Guixé

Titular Profesor

Biology

UNIVERSIDAD DE CHILE

Santiago, Chile

1
Yenniffer Ávalos

Profesor Asistente

Departamento de Biología

Universidad de Santiago de Chile

Santiago, Chile

1
Sebastián Illanes

professor, Director of Reproductive Biology Laboratory

Medicine

UNIVERSIDAD DE LOS ANDES

Santiago, Chile

1
Jocelyn Neira

Especialista Profesional

Universidad Andrés Bello

Santiago, Chile

1
Claudio Figueroa

Profesor Asistente

Ciencias Biológicas y Quimicas

Universidad San Sebastian

Santiago, Chile

1
Fabian Tempio

Asistente de Investigación

Instituto de Ciencias Biomédicas

Universidad de Chile

Santiago, Chile

1
Eduardo Roa

Lab manager/Asistente de investigación

Inmunoncología

Fundación Cienca para la Vida

Santiago, Chile

1
Gabriela Tejon

Investigador Postdoctoral

Biología

UNIVERSIDAD DE CHILE

SANTIAGO, Chile

1
Jorge Ferreira

Director

Clinic and Molecular Farmacology

UNIVERSIDAD DE CHILE , FACULTAD DE MEDICINA, ICBM

Santiago, Chile

1
Sergio Wehinger

Académico Asociado

Bioquímica Clínica e Inmunohematología

UNIVERSIDAD DE TALCA

Talca, Chile

1
Gonzalo Ureta

Investigador post doctoral

Fundación Ciencia y Vida

Santiago, Chile

1
Nicole Farfán

Asistente de investigación

instituto de ciencias biomedicas

Universidad del Desarrollo

Santiago, Chile

1
Lorena Salazar

Academico

Instituto Cs Biomédicas

Universidad Autónoma de Chile

Santiago, Chile

1
MARIA MOLINA

Director

Instituto de Ciencias Biomédicas

Universidad de Chile

INDEPENDENCIA, Chile

1
Fabiola Sánchez

Associate Profesor

Immunology

UNIVERSIDAD AUSTRAL DE CHILE

Valdivia, Chile

1
Paola Llanos

Profesor Asistente

Instituto de Investigacion en Ciencias Biomédicas

FACULTAD DE ODONTOLOGIA. UNIVERSIDAD DE CHILE

Santiago, Chile

1
JULIO TAPIA

Full Professor

Program of Cellular and Molecular Biology

UNIVERSIDAD DE CHILE

SANTIAGO, Chile

1
Patricia Diaz

Academic

University of Connecticut Health Center

Farmington, CT, Estados Unidos

1
Rodrigo Acuña

Profesor Asistente Investigador

Medicina

Universidad del Desarrollo

Santiago, Chile

1
Alexis Kalergis

Full Professor

Microbiología

PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE. FACULTAD DE CIENCIAS BIOLÓGICAS

Santiago, Chile

1
Felipe Grunenwald

Postdoctoral Researcher

CIIB

Universidad de Los Andes

santiago, Chile

1
Claudia Saez

Associate Professor

Hematology-Oncology

Pontificia Universidad Católica de Chile

Santiago, Chile

1
Andres Herrada

Principal Investigator

Instituto de Ciencias Biomédicas

Universidad Autónoma de Chile

Talca, Chile

1
ARTURO FERREIRA

FULL PROFESSOR, CHAIR IMMUNOLOGY DISCIPLINARY PROGRAM

IMMUNOLOGY

UNIVERSIDAD DE CHILE

SANTIAGO, Chile

1
Eduardo Karahanian

Professor

INSTITUTO DE CIENCIAS BIOMEDICAS

UNIVERSIDAD AUTONOMA DE CHILE

Santiago, Chile

1
Pablo Díaz

Professional/Scientific advisor

Scientific Affairs

Instituto de Salud Públida de Chile

santiago, Chile

1
Raul Valdevenito

Chair

UNIVERSIDAD DE CHILE, HOSPITAL CLINICO UNIVERSIDAD DE CHILE

Santiago, Chile

1
Enrique Castellón

Profesor Titular.

Oncología Básico-Clínica

UNIVERSIDAD DE CHILE

Santiago, Chile

1
Lorena Salazar

Profesora Asistente

Instituto de Ciencias Biomédicas

Universidad Autónoma de Chile

Lampa, Chile

1
Ethel Velásquez

Directora (t) Centro de Investigaciones Nucleares para Aplicaciones en Salud y Biomedicina

Comisión Chilena de Energía Nuclear

Santiago, Chile

1
Sebastian Bernales

Founder

Merken Biotech

Santiago, Chile

1
Mario Párraga

PROFESOR TITULAR

ANATOMÍA

UNIVERSIDAD DE VALPARAÍSO

Reñaca, Chile

1
Yedy Israel

Profesor Titular

Farmacologia Molecular y Clinica

UNIVERSIDAD DE CHILE, FACULTAD DE CS QUIMICAS Y FARMACÉUTICAS, LAB. FARMACOTERAPIA GÉNICA

Santiago, Chile

1
Eduardo Karahanian

Académico Investigador

Facultad de Ciencias de la Salud

Universidad Autónoma de Chile

Santiago, Chile

1
Gonzalo Encina

Investigador

Instituto de Ciencias e Innovación en Medicina

Universidad del Desarrollo

Santiago, Chile